Williams, A, Griffin, S, Pickard, M and Fricker, RA ORCID: https://orcid.org/0000-0001-8768-510X (2016) Nicotinamide: A Key Player in the Developmental Origins of Parkinson's Disease? In: not found.

[img]
Preview
Text
2016 Williams Nicotinamide_ A Key Player in the Developmental Origins of Parkinson’s Disease_ (I1.001) _ Neurology.pdf - Published Version

Download (1MB) | Preview

Abstract

OBJECTIVE: To investigate the role of vitamin B3 (nicotinamide) on midbrain dopaminergic neuron development. BACKGROUND: The active forms of vitamins A & C are linked to optimal development of neurons . Little is known regarding the role of vitamin B3 even though poor cognitive development and parkinsonism were features of pellagra . DESIGN/METHODS: Monolayer mouse embryonic stem cell cultures (mESC; Sox1GFP knock-in 46C cell line) were treated with nicotinamide for different durations and immunocytochemistry/ fluorescence microscopy was performed to assess the expression of stem cell, neural progenitor (NP) and neuronal subtype markers. RESULTS: Nicotinamide accelerated the conversion process of mESCs to neurons with a catecholaminergic phenotype. Specifically, the proportion of proliferating cells was significantly reduced in nicotinamide-treated cultures - that is, nicotinamide regulates the proliferation-to-differentiation switch from NPs to neurons during development. Nicotinamide drives dopamine neuron differentiation (10mM) as effectively as known cocktails of signalling factors, and acts in a dose-dependent manner in a defined time-window - with high doses (20mM) however causing toxicity. CONCLUSIONS: Nicotinamide aids the conversion of stem cells to dopaminergic neurons increasing efficiency and safety of the cells produced, and reducing cost; important as we progress towards patient-specific cell replacement therapy for Parkinson’s . Our data also suggest that nicotinamide is a key signalling factor required in a definable dosage range at key times for the formation of a healthy population of dopamine neurons. An optimal maternal to foetal dietary dosage of nicotinamide - neither too low nor too high - could be linked to Parkinson’s disease later in life.

Item Type: Conference or Workshop Item (Lecture)
Additional Information: The final version of this publications/conference information, and all relevant information related to it, including copyrights, can be found online at; https://n.neurology.org/content/86/16_Supplement/I1.001
Subjects: R Medicine > R Medicine (General)
R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
Divisions: Faculty of Medicine and Health Sciences > School of Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 10 Nov 2021 08:45
Last Modified: 10 Nov 2021 08:45
URI: https://eprints.keele.ac.uk/id/eprint/10253

Actions (login required)

View Item View Item